Shareholders elect all 14 director nominees and approve executive compensation at annual meeting

(2) The stockholders approved the non-binding advisory resolution regarding the compensation of the Company’s named executive officers: For Against Abstain Broker Non-Votes 81,701,049 1,814,301 540,013 27,004,521

(1) The stockholders elected each of the following persons as a director of the Company for a term that expires at the Company’s 2027 annual meeting of stockholders and until his or her respective successor has been elected and has qualified: Name For Against Abstain Broker Non-Votes (a) Susan W. Brooks 81,095,873 2,891,262 68,228 27,004,521 (b) Lt. Gen. Ronald L. Burgess, Jr. 83,645,103 359,126 51,134 27,004,521 (c) John A. Clerico 83,505,387 497,636 52,340 27,004,521 (d) Michael Dinkins 83,513,832 490,398 51,133 27,004,521 (e) James S. Ely III 83,500,803 502,207 52,353 27,004,521 (f) John A. Fry 82,997,112 1,006,438 51,813 27,004,521 (g) Kevin J. Hammons 83,604,879 417,857 32,627 27,004,521 (h) Joseph A. Hastings, D.M.D. 83,653,444 358,347 43,572 27,004,521 (i) Elizabeth T. Hirsch 83,640,131 365,264 49,968 27,004,521 (j) William Norris Jennings, M.D. 83,228,046 778,850 48,467 27,004,521 (k) K. Ranga Krishnan, MBBS 83,223,787 766,268 65,308 27,004,521 (l) Fawn D. Lopez 83,268,829 717,

(3) The stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026: For Against Abstain Broker Non-Votes 110,561,632 351,405 146,847 n/a